References
- Almeida, A.J., and Souto, E., 2007. Solid lipid nanoparticles as a drug delivery system for peptides and proteins. Advanced drug delivery reviews, 59 (6), 478–490.
- American Cancer Society 2019. Key statistics of small cell lung cancer Atlanta.
- Arbyn, M., et al., 2018. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors. Cochrane database systemic review, 5, CD009069.
- Arulselvan, P., et al., 2016. Anti-inflammatory potential of ethyl acetate fraction of moringa oleifera in downregulating the NF-κB signaling pathway in lipopolysaccharide-stimulated macrophages. Molecules, 21 (11), 1452.
- Azmi, F., et al., 2014. Recent progress in adjuvant discovery for peptide-based subunit vaccines. Human vaccines & immunotherapeutics, 10 (3), 778–796.
- Behzadi, S., et al., 2017. Cellular uptake of nanoparticles: journey inside the cell. Chemical society reviews, 46 (14), 4218–4244.
- Bragta, P., et al., 2018. Intratumoral administration of carboplatin bearing poly (ε-caprolactone) nanoparticles amalgamated with in situ gel tendered augmented drug delivery, cytotoxicity, and apoptosis in melanoma tumor. Colloids and surfaces B: biointerfaces, 166, 339–348.
- Butts, C., et al., 2005. Randomized phase IIB trial of BLP25 liposome vaccine in stage IIIB and IV non-small-cell lung cancer. Journal of clinical oncology: official journal of the american society of clinical oncology, 23 (27), 6674–6681.
- Chaturvedi, A.K., et al., 2011. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. Journal of clinical oncology, 29 (32), 4294–4301.
- Chen, H., et al., 2014. Recent progress in development of new sonosensitizers for sonodynamic cancer therapy. Drug discovery today, 19 (4), 502–509.
- Cho, W.-S., et al., 2014. Surface functionalization affects the zeta potential, coronal stability and membranolytic activity of polymeric nanoparticles. Nanotoxicology, 8 (2), 202–211.
- Croce, M.V., et al., 2001. Humoral immune response induced by the protein core of MUC1 mucin in pregnant and healthy women. Breast cancer research and treatment, 69 (1), 1–11.
- D'Errico, G., et al., 2017. A current perspective on cancer immune therapy: Step-bystepapproach to constructing the magic bullet. Clinical and translational medicine, 6 (1), 3.
- Dhami, N.K., et al., 2014. Non-aggregated protamine-coated poly(lactide-co-glycolide) nanoparticles of cisplatin crossed blood-brain barrier, enhanced drug delivery and improved therapeutic index in glioblastoma cells: in vitro studies. Journal of microencapsulation, 31 (7), 685–693.
- Finke, J.H., et al., 2014. Coumarin 6 as a fluorescent model drug: How to identify properties of lipid colloidal drug delivery systems via fluorescence spectroscopy? European journal of lipid science and technology, 116 (9), 1234–1246.
- Foged, C., et al., 2005. Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model. International journal of pharmaceutics, 298 (2), 315–322.
- Forest, V., and Pourchez, J., 2017. Preferential binding of positive nanoparticles on cell membranes is due to electrostatic interactions: A too simplistic explanation that does not take into account the nanoparticle protein corona. Materials science & engineering. C, materials for biological applications, 70 (Pt 1), 889–896.
- Fröhlich, E., 2012. The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles. International journal of nanomedicine, 7, 5577–5591.
- Gaus, K., Rodriguez, M., et al., 2005. Domain-specific lipid distribution in macrophage plasma membranes. Journal of lipid research, 46 (7), 1526–1538.
- Gillison, M.L., Chaturvedi, A.K., and Lowy, D.R., 2008. HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women. Cancer, 113 (10 Suppl), 3036–3046.
- Guo, C., et al., 2013. Therapeutic cancer vaccines: past, present, and future. Advances in cancer research, 119, 421–475.
- Hojaee, S., and Nana-Sinkam, P., 2017. Recent advances in the management of non-small cell lung cancer. F1000Research, 6, 2110.
- Horváti, K., et al., 2018. Surface Layer Modification of Poly(d,l-lactic- co-glycolic acid) Nanoparticles with Targeting Peptide: A Convenient Synthetic Route for Pluronic F127-Tuftsin Conjugate. Bioconjugate chemistry, 29 (5), 1495–1499.
- Jemal, A., et al., 2011. Global cancer statistics. CA: a cancer journal for clinicians, 61 (2), 69–90.
- Jyoti, K., et al., 2020. Non-small cell lung cancer tumour antigen, MUC1 peptide-loaded non-aggregated poly (lactide-co-glycolide) nanoparticles augmented cellular uptake in mouse professional antigen-presenting cells: optimisation and characterisation. Journal of microencapsulation, 37 (1), 14–28.
- Kamruzzaman Selim, K.M., et al., 2007. Surface modification of magnetite nanoparticles using lactobionic acid and their interaction with hepatocytes. Biomaterials, 28 (4), 710–716.
- Kaur, A., et al., 2016. Tetanus toxoid-loaded cationic non-aggregated nanostructured lipid particles triggered strong humoral and cellular immune responses. Journal of microencapsulation, 33 (3), 263–273.
- Kelly, R.J., and Giaccone, G., 2011. Lung Cancer Vaccines. Cancer J, 5, 302–308.
- Lillehoj, E.P., et al., 2013. Cellular and molecular biology of airway mucins. International review of cell and molecular biology, 303, 139–202.
- Lin, P.C., et al., 2014. Techniques for physicochemical characterization of nanomaterials. Biotechnology advances, 32 (4), 711–726.
- Matsuo, K., et al., 2011. Intranasal immunization with poly(γ-glutamic acid) nanoparticles entrapping antigenic proteins can induce potent tumor immunity. Jorunal control release, 152 (2), 310–316.
- Mukhopadhyay, A., Dyring, C., and Stott, D.I., 2014. Comparison of prophylactic and therapeutic immunisation with an ErbB-2 (HER2) fusion protein and immunoglobulin V-gene repertoire analysis in a transgenic mouse model of spontaneous breast cancer. Vaccine, 32 (8), 1012–1018.
- Nagpal, M., et al., 2019. Optimization of sulfation of okra fruit gum for improved rheological and pharmacological properties. International journal of biological macromolecules, 122, 1–9.
- Navada, S., et al., 2006. Temporal trends in small cell lung cancer: Analysis of the national Surveillance, Epidemiology, and End-Results (SEER) database. Journal of clinical oncology, 24 (18_suppl), 7082–7082.
- Nembrini, C., et al., 2011. Nanoparticle conjugation of antigen enhances cytotoxic T-cell responses in pulmonary vaccination. Proceedings of the national academy of sciences of the united states of america, 108 (44), E989–97.,
- Nicolete, R., dos Santos, D.F., and Faccioli, L.H., 2011. The uptake of PLGA micro or nanoparticles by macrophages provokes distinct in vitro inflammatory response. International immunopharmacology, 11 (10), 1557–1563.
- Qin, H., et al., 2018. New advances in immunotherapy for non-small cell lung cancer. Am J transl result, 10, 2234–2245.
- Saini, J., et al., 2014. Bleomycin sulphate loaded nanostructured lipid particles augment oral bioavailability, cytotoxicity and apoptosis in cervical cancer cells. Colloids and surfaces B: biointerfaces, 118, 101–110.
- Sandoval, F., et al., 2013. Mucosal imprinting of vaccine-induced CD8+ T cells is crucial to inhibit the growth of mucosal tumors. Science translational medicine., 5, 172.
- Sangha, R., and Butts, C., 2007. L-BLP25: a peptide vaccine strategy in non small cell lung cancer. Clin cancer res, 13, 4652–4654.
- Sharma, S., et al., 2016. Protamine coated proliposomes of recombinant human insulin encased in Eudragit S100 coated capsule offered improved peptide delivery and permeation across Caco-2 cells. Materials science and engineering: c, 67, 378–385.
- Syn, N.L., et al., 2017. De-novo and acquired resistance to immune checkpoint targeting. The lancet oncol, 18, 731–741.
- Taciak, B., et al., 2018. Evaluation of phenotypic and functional stability of RAW 264.7 cell line through serial passages. PLoS one, 13 (6), e0198943.
- Win, K.Y., and Feng, S.S., 2005. Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Biomaterials, 26 (15), 2713–2722.
- Zaman, M., Chandrudu, S., and Toth, I., 2013. Strategies for intranasal delivery of vaccines. Drug delivery and translational research, 3 (1), 100–109.